Omeros (OMER) FCF Margin Growth (5y) (2015 - 2026)
Omeros (OMER) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11,042.00 |
| Mar 31, 2026 | 4,456.00 |
| Jun 30, 2022 | -14,373.00 |
| Mar 31, 2022 | -11,295.00 |
| Dec 31, 2021 | 10,744.00 |
| Sep 30, 2021 | 2,056.00 |
| Jun 30, 2021 | 3,220.00 |
| Mar 31, 2021 | 3,294.00 |
| Dec 31, 2020 | 7,635.00 |
| Sep 30, 2020 | 31,578.00 |
| Jun 30, 2020 | 24,377.00 |
| Mar 31, 2020 | 446,501.00 |
| Dec 31, 2019 | 865,719.00 |
| Sep 30, 2019 | 742,888.00 |
| Jun 30, 2019 | 3.39 Mn |
| Mar 31, 2019 | 1.11 Mn |
| Dec 31, 2018 | 10,238.00 |
| Sep 30, 2018 | 485,400.00 |
| Jun 30, 2018 | 483,006.00 |
| Mar 31, 2018 | 10,417.00 |